Adipose tissue compensates for defect of phosphatidylinositol 3′-kinase induced in liver and muscle by dietary fish oil in fed rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 1, 2006, Pages

  Corporeau, Charlotte ^a   Le Foll, Christelle ^a   Taouis, Mohammed ^b   Gouygou, Jean Paul ^c   Bergé, Jean Pascal ^c   Delarue, Jacques ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c IFREMER   (France)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Insulin resistance; Polyunsaturated fatty acids

Indexed keywords

DEXAMETHASONE; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GLUCOSE; GLUCOSE TRANSPORTER 4; ICOSAPENTAENOIC ACID; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; EDIBLE OIL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; OMEGA 6 FATTY ACID; PHOSPHOPROTEIN; SLC2A4 PROTEIN, RAT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFECT; INSULIN RESPONSE; LIVER; LOW FAT DIET; MALE; MUSCLE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; BODY WEIGHT; CELL MEMBRANE; DRUG EFFECT; EATING; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; ORAL DRUG ADMINISTRATION; PHOSPHORYLATION; SKELETAL MUSCLE; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE TISSUE; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL MEMBRANE; DEXAMETHASONE; DIETARY FATS, UNSATURATED; EATING; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, INSULIN;

EID: 33644876352     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00200.2005     Document Type: Article

References (42)

1. Adamo M, Simon J, Rosebrough RW, McMurtry JP, Steelke NC, and LeRoith D. Characterization of the chicken muscle insulin receptor. Gen Comp Endocr 68: 456-465, 1987.
2. Balbis A, Baquiran G, Bergeron JJ, and Posner BI. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver. Endocrinology 141: 4041-4049, 2000.
3. Berge JP, Gouygou JP, Dubacq JP, and Durand P. Reassessment of lipid composition of the diatom Skeletonema costatum. Phytochemistry 39: 1017-1021, 1995.
4. Berge JP, Debiton E, Dumay J, Durand P, and Barthomeuf C. In vitro anti-inflammatory and anti-proliferative activity of sulfolipids from the red alga Porphyridium cruentum. J Agric Food Chem 50: 6227-6232, 2002.
5. Bjornholm M, Kawano Y, Lehtihet M, and Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997.
6. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
7. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, and DeFronzo RA. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45: 915-925, 1996.
8. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88: 787-835, 2004.
9. Delarue J, LeFoll C, Corporeau C, and Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 44: 289-299, 2004.
10. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, and Newsholme EA. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 321: 707-712, 1997.
11. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, Riou JP, and Vidal H. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50: 1134-1342, 2001.
12. Haber RS and Weinstein SP. Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 41: 728-735, 1992.
13. Holness MJ, Greenwood GK, Smith ND, and Sugden MC. Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 144: 3958-3968, 2003.
14. Inoue G, Cheatham B, Emkey R, and Kahn CR. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J Biol Chem 273: 11548-11555, 1998.
15. Ito Y, Ariga M, Takahashi SI, Takenaka A, Hidaka T, and Noguchi T. Changes in tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 (IRS-1) and association of p85 subunit of phosphatidylinositol 3-kinase with IRS-1 after feeding in rat liver in vivo. J Endocr 154: 267-273, 1997.
16. Inukai K, Funaki M, Ogihara T, Katagiri H, Kanda A, Anai M, Fukushima Y, Hosaka T, Suzuki M, Shin BC, Takata K, Yazaki Y, Kikuchi M, Oka Y, and Asano T. p85α Gene generates three isoforms of regulatory subunit for phosphatidyl-inositol 3-kinase, p50α, p55α, and p85α, with different PI 3-kinase activity elevating responses to insulin. J Biol Chem 272: 7873-7882, 1997.
17. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, and Zierath JR. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292, 2000.
18. Luo J, Rizkalla SW, Vidal H, Oppert JM, Colas C, Boussairi A, Guerre-Millo M, Chapuis AS, Chevalier A, Durand G, and Slama G. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21: 717-724, 1998.
19. Misra S, Ghosh A, and Varticovski L. Naturally occurring ether-linked phosphatidylcholine activates phosphatidylinositol 3-kinase and stimulates cell growth. J Cell Biochem 55: 146-153, 1994.
20. Mol HGJ, Janssen HG, and Cramers CA. Large volume sample introduction using temperature programmable injectors: implications of liner diameter. J High Res Chromatogr 18: 19-27, 1995.
21. Montori VM, Farmer A, Wollan PC, and Dinneen SF. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23: 1407-1415, 2000.
22. Napoli R, Hirshman MF, and Horton ES. Mechanisms of increased skeletal muscle glucose transport activity after an oral glucose load in rats. Diabetes 44: 1362-1368, 1995.
23. Oda N, Nakai A, Mokuno T, Sawai Y, Nishida Y, Mano T, Asano K, Itoh Y, Kotake M, and Kato S. Dexamethasone-induced changes in glucose transporter 4 in rat heart muscle, skeletal muscle and adipocytes. Eur J Endocrinol 133: 121-126, 1995.
24. Puhakainen I, Ahola I, and Yki-Jarvinen H. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 61: 121-126, 1995.
25. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, and Riccardi G. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19: 1207-1213, 1996.
26. Rizkalla SW, Alamowitch C, Luo J, Bruzzo F, Boillot A, Chevalier A, and Slama G. Effect of dietary fish oil on insulin action in fat cells of control and non-insulin-dependent rats. Ann NY Acad Sci 683: 213-217, 1993.
27. Ryder JW, Yang J, Galuska D, Rincon J, Bjornholm M, Krook A, Lund S, Pedersen O, Wallberg-Henriksson H, Zierath JR, and Holman GD. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49: 647-654, 2000.
28. Saad MJ, Folli F, Kahn JA, and Kahn CR. Modulation of insulin receptor, insulin receptor substrate-1 (IRS-1) and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone treated rats. J Clin Invest 92: 2065-2072, 1993.
29. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, and Kahn BB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268: 22243-22246, 1993.
30. Shepherd PR, Withers DJ, and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling (Review). Biochem J 333: 471-490, 1998 [Erratum in Biochem J 335: 711, 1998].
31. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
32. Simoncikova P, Wein S, Gasperikova D, Ukropec J, Certik M, Klimes I, and Sebokova E. Comparison of the extrapancreatic action of gammalinolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance [corrected]. Endocr Regul 36: 143-149, 2003 [Erratum in: Endocr Regul 37: 20, 2003].
33. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, and Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 40: 280-289, 1991.
34. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, and Pascoe WS. Fish oil prevents insulin resistance induced by high fat feeding in rats. Science 237: 885-888, 1987.
35. Taouis M, Dagou C, Ster C, Durand G, Pinault M, and Delarue J. n-3 Polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am J Physiol Endocrinol Metab 282: E664-E671, 2002.
36. Taouis M, Derouet M, Caffin JP, Chavanieu A, and Simon J. Insulin receptor, and insulin sensitivity in a chicken hepatoma cell line. Mol Cell Endocrinol 96: 113-123, 1993.
37. Tappy L, Randin D, Vollenweider P, Vollenweider L, Paquot N, Scherrer U, Schneiter P, Nicod P, and Jequier E. Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 79: 1063-1069, 1994.
38. Tozzo E, Gnudi L, and Kahn BB. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138: 1604-1611, 1997.
39. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, and Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 44: 312-319, 2001.
40. Weinstein SP, Wilson CM, Pritsker A, and Cushman SW. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism 47: 3-6, 1998.
41. Yang J, Clarke JF, Ester CJ, Young PW, Kasuga M, and Holman GD. Phosphatidylinositol 3-kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem J 313: 125-131, 1996.
42. Yeh JI, Gulve EA, Rameh L, and Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270: 2107-2111, 1995.